Open Access
Research (Published online: 17-09-2018)
12. Evaluation of specific and non-specific immune response of four vaccines for caseous lymphadenitis in sheep challenged
Sohier M. Syame, Azza S. M. Abuelnaga, Eman S. Ibrahim and Ashraf S. Hakim
Veterinary World, 11(9): 1272-1276

Sohier M. Syame: Department of Microbiology and Immunology, National Research Centre, Dokki, Cairo, Egypt.
Azza S. M. Abuelnaga: Department of Microbiology and Immunology, National Research Centre, Dokki, Cairo, Egypt.
Eman S. Ibrahim: Department of Microbiology and Immunology, National Research Centre, Dokki, Cairo, Egypt.
Ashraf S. Hakim: Department of Microbiology and Immunology, National Research Centre, Dokki, Cairo, Egypt.

doi: 10.14202/vetworld.2018.1272-1276

Share this article on [Facebook] [LinkedIn]

Article history: Received: 17-05-2018, Accepted: 31-07-2018, Published online: 17-09-2018

Corresponding author: Sohier M. Syame


Citation: Syame SM, Abuelnaga ASM, Ibrahim ES, Hakim AS (2018) Evaluation of specific and non-specific immune response of four vaccines for caseous lymphadenitis in sheep challenged, Veterinary World, 11(9): 1272-1276.

Background: Caseous lymphadenitis (CLA) is a serious disease affects sheep and goat, caused by Corynebacterium pseudotuberculosis. Due to it is non-treatable disease, so the effective preventive vaccines are considered a significant way to combat the disease. All strains of C. pseudotuberculosis have several virulence factors that associated with their cell invasion, survival, and proliferation such as phospholipase D (PLD), outer lipid coat, and secreted proteases.

Aim: The present study was directed to perform a comparative innate and acquired immune response assessment of different four vaccine formulas to evoke protection against induced (CLA) challenge in sheep.

Materials and Methods: Negative ELISA (free of CLA) 15 local breed male (Balady) sheep were divided into five groups, each has received a different vaccine while the control has received saline buffer. The first vaccine composed of toxoid PLD alone the second composed of toxoid PLD with bacterin (formalinkilled bacteria), the third vaccine composed of toxoid PLD plus covaccine 8, while the fourth one composed of toxoid PLD plus locally produced polyvalent clostridial vaccine. The specific immune response was evaluated through lymphocyte proliferation assay using ELISA BrdU kit, while the non-specific response was estimated by superoxide anion production and lysozyme activity assays.

Results: The study revealed that PLD toxoid could evoke the highest specific immune response, showing a stimulation index (9.12%). On the other hand, combined toxoid PLD with bacterin followed by PLD toxoid showed a significant increase in the non-specific innate immune response.

Conclusion: The present study indicated that the toxoid PLD alone vaccine was most efficient and provided innate and acquired immune response in animals against CLA.

Keywords: Corynebacterium pseudotuberculosis, immune response, lymphocyte, phospholipase D, vaccine.


1. Jesse, F.F.A., Bitrus, A.A., Abba, Y., Chung, E.L.T., Sadiq, M.A., Hambali, I.U., Perera, H., Haron, A.W., Lila, M.A.M., Saharee, A.A., Norsidin, M.J. and Harith, A. (2016) Strategic management of a clinical case of recurrent caseous lymphadenitis in a goat farm. Res. J. Vet. Pract., 4(3): 42-46. [Crossref]

2. Nassar, A.F., Gabriela, T.D., Regina R., Simone M., Eloisa M. S., Juraci N. and Lilian G. (2015) Diagnostic comparison of Corynebacterium pseudotuberculosis through microbiological culture and PCR in sheep samples. Arq. Inst. Biol., 82: 1-6.

3. Colom-Cadena, A., Velarde, R., Salinas, J., Borge C., Garcia-Bocanegra, I., Serrano, E., Glasso, D., Bach, E. and Casas-Diaz, E. (2014) Management of a caseous lymphadenitis outbreak in a new Iberian ibex (Capra pyrenaica) stock reservoir. Acta Vet. Scand., 56: 83-94. [Crossref] [PubMed] [PMC]

4. Pepin, M., Fontaine, J.J., Pardon, P., Marly, J. and Parodi, A.L. (1991) Histopathology of the early phase during experimental Corynebacterium pseudotuberculosis infection in lambs. Vet. Microbiol., 29: 123-134. [Crossref]

5. Pepin, M., Pittet, J.C., Olivier, M. and Gohin, I., (1994b) Cellular composition of Corynebacterium pseudotuberculosis pyogranulomas in sheep. J. Leukoc. Biol., 56: 666-670. [Crossref] [PubMed]

6. Dar, L.M., Hussain, S.A., Rashid, A., Parihar, S., Abdullah, S. and Rather, F. A. (2013) Caseous lymphadenitis in a sheep-postmortem and histopathological findings. Int. J. Livestock Res., 3(3): 69-73.

7. Flores-Diaz, M., Monturiol-Gross, L., Naylor, C., Alape-Giron, A. and Antje, F. (2016) Bacterial sphingomyelinases and phospholipases as virulence factors. Microbiol. Mol. Biol. Rev., 80(3): 597-628. [Crossref] [PubMed] [PMC]

8. Santos, E.M.S., Santos, H.O., Cangussu, A.R. Costa, K.S. and Dias, I. (2016) Antigens of Corynebacterium pseudotuberculosis with promising potential for caseous lymphadenitis vaccine development. Cad. Cienc. Agra., 8(2): 90-99.

9. Bastos, B.L., Dias Portela, R.W., Dorella, F.A., Ribeiro, D. and Seyffert, N. (2012) Corynebacterium pseudotuberculosis: Immunological responses in animal models and zoonotic potential. J. Clin. Cell. Immunol., S4: 5. [Crossref]

10. Brown, C.C., Olander, H.J., Biberstein, E.L. and Morse, S.M. (1986) Use of a toxoid vaccine to protect goats against intradermal challenge exposure to Corynebacterium pseudotuberculosis. Am. J. Vet. Res., 47: 1116-1119. [PubMed]

11. Syame, S.M. (2006) Characterization of Secretory Proteins that Secreted from Corynebacterium pseudotuberculosis. Ph.D. Thesis., Bacteriology, Fac. Vet. Med., Cairo Univ, Giza, Egypt.

12. Selim, S.A., Syame, S. M., Ebessy, E. A. Effat, M.M., Hakim, A.S. and Balata, M.A. (2016) Evaluation of protective efficacy of mixed PLD toxoid and clostridial vaccines against caseous lymphadenitis (CLA) in small ruminants at Egypt. Int. J. Microbiol. Res., 7(3): 102-113.

13. Moussa, I.M., Mohamed, S.A., Hessain, A.M., Kabli, S.A., Hemeg, H.A. and Selim, S.A. (2016) Vaccination against Corynebacterium pseudotuberculosis infections controlling caseous lymphadenitis (CLA) and oedematous skin disease. Saudi. J. Biol. Sci., 23(6): 718-723. [Crossref] [PubMed] [PMC]

14. Eggleton, D.G., Doidge, C.V. Middleton, H.D. and Minty, D.W. (1991) Immunisation against ovine caseous lymphadenitis: Efficacy of component Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-coryne bacterial vaccines. Aust. Vet. J., 68: 320-321. [Crossref] [PubMed]

15. Masoud, R., Bizouarn, T., Trepout, S., Wien, F., Baciou, L. and Marco, S. (2015) Titanium dioxide nanoparticles increase superoxide anion production by acting on NADPH oxidase. PLoS One, 10(12): 1-17. [Crossref] [PubMed] [PMC]

16. Jiang, Z.L. and Huang, G.X. (2007) Resonance scattering spectra of Micrococcus lysodeikticus and its application to assay of lysozyme activity. Clin. Chim. Acta, 376: 136-141. [Crossref] [PubMed]

17. Helal, R. and Melzig M.F. (2008) Determination of lysozyme activity by a fluorescence technique in comparison with the classical turbidity assay. Pharmazie, 63: 415-419. [PubMed]

18. Hogan, J.S., Smith, K.L., Weiss, W.P., Todhunter, D.A. and Schockey, W.L. (1990) Relationships among Vitamin E, selenium, and bovine blood neutrophils. J. Dairy. Sci., 73(9): 2372-2378. [Crossref]

19. Perros, P. and Weightman, D.R. (1991) Measurement of cell proliferation by enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody to bromodeoxyuridine. Cell Prolif., 24: 517-523. [Crossref] [PubMed]

20. SAS. (2000) Step-by-Step Programming with Base SAS Software. SAS Institute Inc, Cary NC.

21. Ribeiro, D., Dorella, F.A., Pacheco, L.G.C., Thiago, L.C., Portela, R.W.D., Meyer, R., Miyoshi, A., Luvizotto, M.C.R. and Vasco, A. (2013) Subclinical diagnosis of caseous lymphadenitis based on ELISA in sheep from Brazil. J. Bacteriol. Parasitol., 4(3): 1-4.

22. Vance, R.E. (2010) Inflammasome activation: How macrophages watch what they eat. Cell Host Microb., 21: 3-5. [Crossref] [PubMed]

23. McKean, S., Davies, J. and Moore, R. (2005) Identification of macrophage-induced genes of Corynebacterium pseudotuberculosis by differential fluorescence induction. Microb. Infect., 7: 1352-1363. [Crossref] [PubMed]

24. Moura-Costa, L.F., Bahia, R.C., Carminati, R., Vale, V.L., Paule, B.J., Portela, R.W., Freire, S.M., Nascimento, I., Schaer, R., Barreto, L.M. and Meyer, R. (2008) Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Caninde goats and their potential protection against caseous lymphadenitis. Vet. Immunol. Immunopathol., 15: 131-41. [Crossref] [PubMed]

25. Vera, L., Costa, V., Marcos, C. S., Andreia, P. S., Soraya, C. T., Lilia, F. de Moura, C. (2016) Humoral and cellular immune responses in mice against secreted and somatic antigens from a Corynebacterium pseudotuberculo sis attenuated strain: Immune response against a C. pseudotuberculosis strain. BMC Vet. Res., 12(1): 195. [Crossref] [PubMed] [PMC]

26. Kitanaka, S. (2016) Chemical compounds in natural medicines that affect macrophages and adipocyte cells. Yakugaku Zasshi, 136(9): 1195-216. [Crossref] [PubMed]

27. El-Enbaawy, M.I., Saad, M.M. and Selim, S.A. (2005) Humoral and cellular immune responses of a murine model against Corynebacterium pseudotuberculosis antigens. Egypt J. Immunol., 12: 13-19. [PubMed]

28. Dorella, F.A., Pacheco, L.G., Seyffert, N., Portela, R.W., Meyer, R., Miyoshi, A. and Azevedo, V. (2009) Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development. Expert Rev. Vaccine, 8(2): 205-213. [Crossref] [PubMed]